{
  "ticker": "EW",
  "year": 2023,
  "quarter": 1,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 59,
  "transactions": [
    {
      "id": 52573,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 88419,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 131898,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 181770,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 52531,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 52571,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88361,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 88415,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131831,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 131894,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181696,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 181765,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52535,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 88367,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 131837,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 181702,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 52551,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 52562,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 52602,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 88388,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 88404,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 88458,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 131863,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 131881,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 131942,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 181729,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 181750,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 181817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 52553,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 52569,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 88390,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 88413,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 131865,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 131892,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 181731,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 181762,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52565,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88408,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131886,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181756,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52529,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88355,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131825,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181689,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52552,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 88389,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 131864,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 181730,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27853,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52595,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88450,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131934,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27790,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52519,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88334,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181662,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    }
  ]
}